Maiga Alassane Baneye, Arama Abdoulaye, Yalcouyé Abdoulaye, Albakaye Mohamed, Weizhen Ji, Bamba Salia, Traoré Oumou, Sangaré Moussa, Kotioumbé Mahamadou, Djimdé Samba Ogomaly, Goita Modibo K, Diarra Salimata, Khokha Mustafa K, Lakhani Saquib A, Landouré Guida
Faculté de Médecine et d'Odontostomatologie, Université des Sciences, des Techniques et des Technologies de Bamako, P.O BOX: 1805, Bamako, Mali.
Centre de Santé Communautaire (CSCOM), Fegui, Kayes, Mali.
Neurogenetics. 2025 Mar 11;26(1):35. doi: 10.1007/s10048-025-00814-x.
Metachromatic Leukodystrophy (MLD) is a rare autosomal recessive lysosomal disorder caused by ARSA gene variants, affecting central and peripheral nervous systems. While ARSA variants are reported globally, data from sub-Saharan Africa (SSA) are limited. We report the first SSA case, a Malian patient with a rare phenotype: predominant tonic seizures without typical peripheral neuropathy signs. The patient harbored a novel ARSA variant (c.191T > C; p.Phe64Ser), predicted deleterious by in silico tools. This case expands the genetic and phenotypic spectrum of MLD, underscoring the need for genetic studies in underrepresented regions.
异染性脑白质营养不良(MLD)是一种由ARSA基因变异引起的罕见常染色体隐性溶酶体疾病,会影响中枢和周围神经系统。虽然全球都有ARSA变异的报告,但撒哈拉以南非洲(SSA)的数据有限。我们报告了首例SSA病例,一名来自马里的患者,具有罕见的表型:以强直性癫痫发作为主,无典型的周围神经病变体征。该患者携带一种新的ARSA变异(c.191T > C;p.Phe64Ser),计算机模拟工具预测该变异有害。该病例扩展了MLD的遗传和表型谱,强调了在代表性不足地区开展基因研究的必要性。